KELLY CRIM: Open Payments
NPI 1841838125 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 13 payments from 11 companies in 2025. Trend: 2023 $254 · 2024 $271 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $26 |
| Becton, Dickinson and Company | 1 | $26 |
| Organogenesis Inc. | 1 | $26 |
| MILLICENT US INC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Kerecis Limited | 1 | $17 |
| Solventum Corporation | 1 | $17 |
Products named: ZURZUVAE, Qelbree, Phasix Mesh, AFFINITY, FEMLYV, MYFEMBREE, STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS, Kerecis SurgiClose.
Industry payments across LA — which companies pay providers there.
